Eligard 6 Month
What it is used for
Eligard is indicated for the: – Palliative treatment of advanced prostate cancer – Treatment of high-risk localised and locally advanced hormone-dependent prostate cancer in combination with radiotherapy
How to take it
This medicine is a pack that contains more than one part.
Part 1: Injection, modified release
White to off-white powder; substantially free of foreign matter. No evidence of meltback.
The way to take this medicine is: Subcutaneous. This medicine is injected, usually with a short needle or pen-like device, into the fat just beneath the skin.
Part 2: Injection, modified release
Colourless to pale yellow, clear, viscous solution. May contain air bubbles but is substantially free of visible particles and foreign matter
The way to take this medicine is: Subcutaneous. This medicine is injected, usually with a short needle or pen-like device, into the fat just beneath the skin.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
How to take it
This medicine is a pack that contains more than one part.
Part 1: Injection, modified release
White to off-white powder; substantially free of foreign matter. No evidence of meltback.
The way to take this medicine is: Subcutaneous. This medicine is injected, usually with a short needle or pen-like device, into the fat just beneath the skin.
Part 2: Injection, modified release
Colourless to pale yellow, clear, viscous solution. May contain air bubbles but is substantially free of visible particles and foreign matter
The way to take this medicine is: Subcutaneous. This medicine is injected, usually with a short needle or pen-like device, into the fat just beneath the skin.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Pregnant or planning a pregnancy?
For the active ingredient leuprorelin
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Is this medicine subsidised?
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on March 1, 2020. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
